2 Patents
- US123702572025Materials and Methods of Treating Mhc-i-opathy Risk Haplotypes
Regeneron Pharmaceuticals, Inc.
0 cites - US121578912024Treatment of Uveitis with Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites